Category | Top 50 Pharma

Baxter: Company Profile

Posted on 13 May 2013

Baxter is a global healthcare company with expertise in medical devices, pharmaceuticals and biotechnology

Tags: ,

Otsuka: Company Profile

Posted on 30 April 2013

Otsuka, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years

Tags: ,

Sanofi: Partnering activity 2005-2013

Posted on 30 April 2013

Sanofi announced over 274 partnering / licensing deals since 2005, with over 33 deals in 2012 alone

Tags: , , , ,

Novo Nordisk: Company profile

Posted on 23 April 2013

Tags: ,

Daiichi Sankyo: Company Profile

Posted on 17 April 2013

Return to top 50 pharma list Summary Website: Daiichi Headquarters: Tokyo, Japan Ticker:  D4S (Frankfurt Stock Exchange) SEC: Daiichi Sankyo Recent deal news: Daiichi Sankyo deal news at Current Partnering Must read report: Partnering Deals and Alliances with Daiichi Sankyo Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. Daiichi Sankyo Co. Ltd. was more »

Tags: ,

Mylan: Company Profile

Posted on 15 March 2013

Mylan is engaged in the development and sale of generic and specialty pharmaceutical products worldwide

Tags: ,

Pharma news: Roche explores expansion options after Illumina fends its hostile bid

Posted on 17 October 2012

The top pharma news hitting the headlines is, Roche’s desire to still expand in gene sequencing after its failed attempt to buy Illumina Inc. (ILMN) this year

Tags: , , , ,

Big Pharma Celgene pharma alliances with PharmAria to advance small molecule therapeutics

Posted on 16 October 2012

Celgene Corporation, a top 50 pharma company has entered into  strategic pharma alliances agreement with PharmAria to advance the discovery of new high quality small-molecule therapeutics targeting cancer and fibrotic diseases

Tags: , , ,

AiCuris enters pharma licensing agreement with Merck for HCMV drug candidates

Posted on 15 October 2012

Merck, a top pharma company have entered into an exclusive worldwide pharma licensing agreement for AiCuris’ novel portfolio of investigational medicines targeting Human Cytomegalovirus (HCMV)

Tags: , , , ,

Pharma news: Abbott plans to make big acquisitions in Russia

Posted on 12 October 2012

The latest pharma news reports that, the rumored Abbott Laboratories deal could be one of the top three largest acquisitions in the history of Russia’s pharmaceutical market

Tags: , , ,

cpbannerad300x150new1gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new1gif
e79banner300x150gif
e78banner300x150animgif